Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Baseline Hemoglobin Predicts Oncologic Outcomes in Intrahepatic Cholangiocarcinoma Treated With Yttrium-90 Radioembolisation: A Retrospective Cohort Study of 136 Patients.

Journal of medical imaging and radiation oncology·2026

Same author

Rates of Successful Bridging or Downstaging and Safety of Segmental Radioembolization for Hepatocellular Carcinoma in Patients with Baseline Hyperbilirubinemia.

Journal of vascular and interventional radiology : JVIR·2026

Same author

Real-World Analysis of Multidisciplinary Roles in the Management of Hepatocellular Carcinoma: The Mayo Clinic Experience.

Journal of hepatocellular carcinoma·2026

Same author

Initial Experience with Robotic-Assisted CT-Guided Ablation: Analysis from a Single Center's Learning Curve in the First 54 Patients.

Journal of vascular and interventional radiology : JVIR·2026

Same author

Incidence of Gastrointestinal Adverse Events Following Left Hepatic Lobe Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma.

Cardiovascular and interventional radiology·2026

Same author

Yttrium-90 Transarterial Radioembolization for Intrahepatic Cholangiocarcinoma: A Comprehensive Review.

Journal of gastrointestinal cancer·2026

Same journal

Imaging, Management, and Treatment of Orbital Trauma.

Radiologic clinics of North America·2026

Same journal

Imaging Findings after Multidisciplinary Treatment for Orbital and Ocular Adnexal Cancers.

Radiologic clinics of North America·2026

Same journal

Orbital Tumors: What the Radiologist Needs to Know from the Orbital Surgeon's Perspective.

Radiologic clinics of North America·2026

Same journal

Multidisciplinary Management of Tumors of the Orbit.

Radiologic clinics of North America·2026

Same journal

Skull Base, Bone, Pituitary-Regions around Orbit that Affect Vision.

Radiologic clinics of North America·2026

Same journal

Imaging of Central Nervous System Diseases that Affect Vision.

Radiologic clinics of North America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 4, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Assessing Imaging Response to Therapy.

Jeet Minocha¹, Robert J Lewandowski²

¹Division of Interventional Radiology, Department of Radiology, University of California San Diego, 200 West Arbor Drive, #8756, San Diego, CA 92103-8756, USA.

Radiologic Clinics of North America

|September 1, 2015

Summary

This summary is machine-generated.

Assessing cancer treatment response using imaging is vital for patient survival. This review covers criteria for evaluating radiologic response to locoregional therapies (LRTs), especially for liver cancer.

Keywords:

Computed tomography (CT)European Association for the Study of the Liver (EASL)MR imaging Modified RECIST (mRECIST)Response assessment Response evaluation criteria in solid tumors (RECIST)World Health Organization (WHO)

More Related Videos

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Related Experiment Videos

Last Updated: Apr 4, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Area of Science:

Oncology
Radiology
Medical Imaging

Background:

Locoregional therapies (LRTs) are important cancer treatments, particularly for liver tumors.
Accurate assessment of treatment response is key, as it can predict patient survival.
Imaging is essential for evaluating tumor response to LRTs, but assessment can be complex.

Purpose of the Study:

To review the criteria for assessing radiologic response to LRTs.
To focus on imaging assessment following treatment for hepatocellular carcinoma.

Main Methods:

Review of existing literature and established criteria for imaging response assessment.
Focus on criteria applicable to locoregional therapies.
Special consideration for hepatocellular carcinoma treatment.

Main Results:

Various criteria exist for assessing imaging response to LRTs.
Hepatocellular carcinoma presents unique challenges in imaging response evaluation.
Evolving methodologies are continually refining assessment techniques.

Conclusions:

Standardized criteria are crucial for objective evaluation of LRT effectiveness.
Imaging plays a pivotal role in monitoring treatment outcomes and guiding clinical decisions.
Continued research is needed to refine imaging assessment in diverse cancer types and treatments.